| Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations (NCT05256290) | Black Diamond Therapeutics, Inc. | 2022-03-31 |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
| A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors (NCT05143970) | Institut Paoli-Calmettes | 2022-01-21 |
| LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG (NCT04790682) | Institut Curie | 2021-05-22 |
| Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer (NCT04940325) | Gustave Roussy, Cancer Campus, Grand Paris | 2021-05-12 |
| Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study (NCT04804137) | University Hospital, Tours | 2021-05-03 |
| DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria (NCT04708483) | Hyperfusion | 2021-01-07 |
| Piloting Pathways With Lung Cancer Patients (NCT04161157) | Laurie McLouth | 2020-01-13 |
| Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer (NCT03867175) | Wake Forest University Health Sciences | 2019-06-24 |
| Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer (NCT03721120) | Centre Leon Berard | 2019-04-10 |
| McMaster Catheterization for Thoracoscopic Surgery Study (NCT02640326) | McMaster University | 2018-12-01 |
| Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) (NCT03198468) | Uptake Medical Technology, Inc. | 2018-11-21 |
| Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases (NCT03143322) | UNICANCER | 2018-07-24 |
| A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126) | Asana BioSciences | 2018-01-19 |
| Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) (NCT03345810) | AIO-Studien-gGmbH | 2017-12-14 |
| Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC (NCT03177291) | H. Lee Moffitt Cancer Center and Research Institute | 2017-09-26 |
| Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers (NCT03073473) | Cota Inc. | 2017-02-28 |
| Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC (NCT03044626) | AIO-Studien-gGmbH | 2017-02-10 |
| Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease (NCT02469701) | howard safran | 2016-02-01 |
| Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects (NCT02310464) | OBI Pharma, Inc | 2015-12-22 |
| A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations (NCT02109016) | Clovis Oncology, Inc. | 2014-04-01 |
| The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel (NCT01814150) | Gottfried Maya | 2013-04-01 |
| Safety and Efficacy of Cryoablation for Metastatic Lung Tumors (NCT01307501) | Boston Scientific Corporation | 2012-01-04 |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously (NCT01543672) | The Netherlands Cancer Institute | 2011-11-22 |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver (NCT00986661) | Provectus Biopharmaceuticals, Inc. | 2009-10-01 |